New Drug Application In Japan For Ponatinib Submitted By ARIAD And Otsuka

ARIAD and Otsuka Submit New Drug Application in Japan for Ponatinib.“The collaborative work to file this new drug application in Japan marks a significant milestone in expanding patient access to Iclusig in major geographies around the world,” said Timothy P. Clackson, Ph.D., president of research and development and chief scientific officer of ARIAD.

URL:
www.businesswire.com/news/home/20160108005281/en/ARIAD-Otsuka-Submit-Drug-Application-Japan-Ponatinib